Rapid Generation of Therapeutic Nanoparticles Using Cell‐Free Expression Systems
- 28 April 2023
- journal article
- research article
- Published by Wiley in Small Methods
- Vol. 7 (12) , e2201718
Abstract
The surface modification of membrane‐based nanoparticles, such as liposomes, polymersomes, and lipid nanoparticles, with targeting molecules, such as binding proteins, is an important step in the design of therapeutic materials. However, this modification can be costly and time‐consuming, requiring cellular hosts for protein expression and lengthy purification and conjugation steps to attach proteins to the surface of nanocarriers, which ultimately limits the development of effective protein‐conjugated nanocarriers. Here, the use of cell‐free protein synthesis systems to rapidly create protein‐conjugated membrane‐based nanocarriers is demonstrated. Using this approach, multiple types of functional binding proteins, including affibodies, computationally designed proteins, and scFvs, can be cell‐free expressed and conjugated to liposomes in one‐pot. The technique can be expanded further to other nanoparticles, including polymersomes and lipid nanoparticles, and is amenable to multiple conjugation strategies, including surface attachment to and integration into nanoparticle membranes. Leveraging these methods, rapid design of bispecific artificial antigen presenting cells and enhanced delivery of lipid nanoparticle cargo in vitro is demonstrated. It is envisioned that this workflow will enable the rapid generation of membrane‐based delivery systems and bolster our ability to create cell‐mimetic therapeutics.Keywords
This publication has 55 references indexed in Scilit:
- Protein Synthesis Using a Reconstituted Cell‐Free SystemCurrent Protocols in Molecular Biology, 2014
- Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccinesProceedings of the National Academy of Sciences, 2013
- Generation and Evaluation of Bispecific Affibody Molecules for Simultaneous Targeting of EGFR and HER2Bioconjugate Chemistry, 2012
- Ligand Mobility Modulates Immunological Synapse Formation and T Cell ActivationPLOS ONE, 2012
- Surface Functionalization of Virus-Like Particles by Direct Conjugation Using Azide−Alkyne Click ChemistryBioconjugate Chemistry, 2011
- Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared ImagingClinical Cancer Research, 2008
- Escherichia coli‐based cell‐free synthesis of virus‐like particlesBiotechnology and Bioengineering, 2007
- Development of cell‐free protein synthesis platforms for disulfide bonded proteinsBiotechnology and Bioengineering, 2007
- Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccinesBlood, 2006
- Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.International Immunology, 1998